Transcat, Inc. (NASDAQ:TRNS) Shares Acquired by Conestoga Capital Advisors LLC

Conestoga Capital Advisors LLC lifted its holdings in shares of Transcat, Inc. (NASDAQ:TRNS) by 17.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 907,191 shares of the scientific and technical instruments company’s stock after acquiring an additional 137,830 shares during the period. Transcat accounts for about 1.5% of Conestoga Capital Advisors LLC’s holdings, making the stock its 25th biggest position. Conestoga Capital Advisors LLC owned approximately 9.91% of Transcat worth $109,561,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Quadrature Capital Ltd purchased a new stake in shares of Transcat in the first quarter valued at about $619,000. Calamos Advisors LLC raised its stake in Transcat by 76.0% during the 2nd quarter. Calamos Advisors LLC now owns 15,441 shares of the scientific and technical instruments company’s stock valued at $1,848,000 after acquiring an additional 6,667 shares during the last quarter. First Horizon Advisors Inc. lifted its position in Transcat by 26.4% during the 2nd quarter. First Horizon Advisors Inc. now owns 599 shares of the scientific and technical instruments company’s stock worth $72,000 after acquiring an additional 125 shares during the period. Quest Partners LLC purchased a new position in shares of Transcat in the 2nd quarter valued at approximately $109,000. Finally, Annex Advisory Services LLC increased its holdings in shares of Transcat by 61.4% in the third quarter. Annex Advisory Services LLC now owns 16,568 shares of the scientific and technical instruments company’s stock valued at $2,001,000 after purchasing an additional 6,304 shares during the period. Hedge funds and other institutional investors own 98.34% of the company’s stock.

Transcat Stock Down 0.5 %

Shares of TRNS traded down $0.46 on Friday, reaching $95.11. The stock had a trading volume of 11,745 shares, compared to its average volume of 52,581. Transcat, Inc. has a twelve month low of $84.45 and a twelve month high of $147.12. The firm has a market capitalization of $870.26 million, a PE ratio of 48.27 and a beta of 0.67. The firm has a 50-day moving average of $122.34 and a 200 day moving average of $121.99.

Transcat (NASDAQ:TRNS) last posted its earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.12). The firm had revenue of $67.83 million during the quarter, compared to analyst estimates of $70.30 million. Transcat had a net margin of 6.63% and a return on equity of 7.62%. The firm’s revenue for the quarter was up 8.0% on a year-over-year basis. During the same period last year, the company posted $0.41 EPS. On average, sell-side analysts anticipate that Transcat, Inc. will post 2.06 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on TRNS shares. Oppenheimer restated an “outperform” rating and set a $130.00 price objective (down previously from $155.00) on shares of Transcat in a research report on Wednesday. StockNews.com lowered Transcat from a “hold” rating to a “sell” rating in a report on Tuesday. HC Wainwright reissued a “buy” rating and set a $156.00 target price on shares of Transcat in a research note on Tuesday. Northland Securities dropped their price objective on Transcat from $130.00 to $110.00 and set a “market perform” rating on the stock in a report on Wednesday. Finally, Craig Hallum reduced their target price on Transcat from $138.00 to $113.00 and set a “buy” rating for the company in a report on Wednesday. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $127.25.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.